Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 3, 2009, Pages 704-705

  Fairley, Janet A ^a,b   Baum, Christian L ^a   Brandt, Debra S ^a   Messingham, Kelly A N ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MINOCYCLINE; OMALIZUMAB; PREDNISONE;

AGED; ANAMNESIS; ANTIBODY BLOOD LEVEL; AUTOIMMUNITY; BLISTER; BULLOUS PEMPHIGOID; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; HEMIDESMOSOME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MINIMAL RESIDUAL DISEASE; MYOSITIS; OUTCOME ASSESSMENT; PATHOGENICITY; PATIENT REFERRAL; PLASMA CLEARANCE; PRIORITY JOURNAL; PRURITUS; TREATMENT DURATION; TREATMENT OUTCOME; URTICARIA;

AGED; ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; FEMALE; HUMANS; IMMUNOGLOBULIN E; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS;

EID: 61549086236     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.11.035     Document Type: Letter

References (7)

1. Dimson O.G., Giudice G.J., Fu C.-L., Warren S.J., Janson M.M., and Fairley J.A. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 120 (2003) 784-788
2. Fairley J.A., Fu C.L., and Giudice G.J. Mapping the binding sites of BP180 IgE autoantibodies in bullous pemphigoid. J Invest Dermatol 125 (2005) 467-472
3. Zone J.J., Taylor T., Hull C., Schmidt L., and Meyer L. IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J Invest Dermatol 127 (2007) 1167-1174
4. Fairley J.A., Burnett C.T., Fu C.-L., Larson D.L., Fleming M.G., and Giudice G.J. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J Invest Dermatol 127 (2007) 2605-2611
5. Holgate S.T., Djukananovic R., Casale T., and Bousquet J. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy 35 (2005) 408-416
6. Corren J., Shapiro G., Reimann J., Deniz Y., Wong D., Adelman A., and Togias A. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy. J Allergy Clin Immunol 121 (2008) 506-511
7. Hamilton R.G., Marcotte G.V., and Saini S.S. Immunologic methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy. J Immunol Methods (2005) 81-91